{
  "id": 11493576,
  "title": "Very low carbohydrate diets linked to health benefits in children with type 1 diabetes",
  "url": "https://urgent.news/2026/10/02/very-low-carbohydrate-diets-linked-to-health-benefits-in-children",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-02T17:40:09.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-10-carbohydrate-diets-linked-health-benefits.html"
  },
  "original_language": "en",
  "account": "New research suggests that very low-carbohydrate (VLC) diets may offer health benefits for children with type 1 diabetes (T1D) without causing acute complications. Led by Professor Christian Denzer from the University Medical Center Ulm and Dr. Belinda Lennerz from Boston Children's Hospital, the study examined the association between VLC diets, growth, and metabolic safety in a large cohort of children with T1D. Over 25 years of data from a diabetes prospective follow-up registry were analyzed, involving 45,569 children aged 1-17 with T1D who had their carbohydrate intake recorded at least twice a year. The children's diets were categorized as very low-carbohydrate (10% carbohydrate), low-carbohydrate (10-26% carbohydrate), or standard/higher-carbohydrate intake (≥26% carbohydrate). The study found no evidence that VLC diets caused stunted growth, severe hypoglycemia, or diabetic ketoacidosis. Instead, children following VLC and low-carbohydrate diets showed improved BMI, glycemic trajectories, and insulin requirements compared to those on standard/higher-carbohydrate diets. The findings suggest that VLC diets may help improve glycemic control and reduce insulin needs in children with T1D, but larger long-term studies are needed to confirm the health benefits and safety of these diets.",
  "summary": "Very low-carbohydrate (VLC) diets may be associated with health benefits in children with type 1 diabetes (T1D) and were not associated with acute diabetes complications, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept. 28–Oct. 2), has found.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}